HomeNDC LookupRxCUI directory › RxCUI 1294343

Pramoxine hydrochloride 10 MG/ML / zinc acetate 1.2 MG/ML Topical Spray — RxCUI 1294343

RxNorm drug concept · Semantic clinical drug
RxCUI 1294343 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1294343
Official namePramoxine hydrochloride 10 MG/ML / zinc acetate 1.2 MG/ML Topical Spray
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspramoxine HCl 1 % / zinc acetate 0.12 % Topical Spray
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pramoxine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Pramoxine is a local anesthetic, which means it temporarily numbs the area where you apply it. It works right at the skin's surface to block the sensation of pain and itching. It d...
  • What exactly does pramoxine do — how does it stop the itching?
  • It depends on which product you have. Most creams, sprays, and solutions are used up to 3 to 4 times daily. Some products, like Proctofoam for the rectal area, can be used up to 5...
  • No. All pramoxine products are for external use only — that means the outside of the skin. Even products intended for the genital or rectal area, like the Terramed Intimate Wash or...
📖 Read our full Pramoxine guide →

🕸️ Concept Web — How Pramoxine hydrochloride 10 MG/ML / zinc acetate... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pramoxine hydrochloride 10 MG/ML / zinc acetate 1.2 MG/ML Topical Spray RxCUI 1294343

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Pramoxine 34347
    • Zinc acetate 58295
    • Pramoxine / zinc acetate 1007357
    • Pramoxine hydrochloride 57555
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pramoxine / zinc acetate Topical Spray 377358
    • Pramoxine hydrochloride / zinc acetate Topical Spray 2645971
    • Pramoxine / zinc acetate Topical Product 1165737
    • Pramoxine hydrochloride / zinc acetate Topical Product 2659802
    • Topical Spray 346165
    • Topical Product 1151122
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Pramoxine hydrochloride 10 MG/ML 828361
    • Zinc acetate 1.2 MG/ML 334578

Showing up to 8 concepts per family — 12 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pramoxine hydrochloride 10 MG/ML SCDC · 828361
  • Zinc acetate 1.2 MG/ML SCDC · 334578
  • Pramoxine / zinc acetate Topical Spray SCDF · 377358
  • Pramoxine hydrochloride / zinc acetate Topical Spray SCDFP · 2645971
  • Pramoxine / zinc acetate Topical Product SCDG · 1165737
  • Pramoxine hydrochloride / zinc acetate Topical Product SCDGP · 2659802

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1294343 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
10157-2100-01 100 mL in 1 BOTTLE, SPRAY (10157-2100-1) Blistex Ivarest Poison Ivy Itch Blistex Inc. 2015-02-02
Observed labelers: Blistex Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.